203 related articles for article (PubMed ID: 25648844)
1. Uptake of clostridium botulinum C3 exoenzyme into intact HT22 and J774A.1 cells.
Rohrbeck A; von Elsner L; Hagemann S; Just I
Toxins (Basel); 2015 Feb; 7(2):380-95. PubMed ID: 25648844
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure and novel recognition motif of rho ADP-ribosylating C3 exoenzyme from Clostridium botulinum: structural insights for recognition specificity and catalysis.
Han S; Arvai AS; Clancy SB; Tainer JA
J Mol Biol; 2001 Jan; 305(1):95-107. PubMed ID: 11114250
[TBL] [Abstract][Full Text] [Related]
3. Vimentin mediates uptake of C3 exoenzyme.
Rohrbeck A; Schröder A; Hagemann S; Pich A; Höltje M; Ahnert-Hilger G; Just I
PLoS One; 2014; 9(6):e101071. PubMed ID: 24967582
[TBL] [Abstract][Full Text] [Related]
4. Cell Entry of C3 Exoenzyme from Clostridium botulinum.
Rohrbeck A; Just I
Curr Top Microbiol Immunol; 2017; 406():97-118. PubMed ID: 27832378
[TBL] [Abstract][Full Text] [Related]
5. Distinct biological activities of C3 and ADP-ribosyltransferase-deficient C3-E174Q.
Rohrbeck A; Kolbe T; Hagemann S; Genth H; Just I
FEBS J; 2012 Aug; 279(15):2657-71. PubMed ID: 22621765
[TBL] [Abstract][Full Text] [Related]
6. The intermediate filament protein vimentin is essential for axonotrophic effects of Clostridium botulinum C3 exoenzyme.
Adolf A; Leondaritis G; Rohrbeck A; Eickholt BJ; Just I; Ahnert-Hilger G; Höltje M
J Neurochem; 2016 Oct; 139(2):234-244. PubMed ID: 27419376
[TBL] [Abstract][Full Text] [Related]
7. ADP-ribosylation of Rho-proteins with botulinum C3 exoenzyme inhibits invasion and shape changes of T-lymphoma cells.
Verschueren H; De Baetselier P; De Braekeleer J; Dewit J; Aktories K; Just I
Eur J Cell Biol; 1997 Jun; 73(2):182-7. PubMed ID: 9208232
[TBL] [Abstract][Full Text] [Related]
8. Selective and specific internalization of clostridial C3 ADP-ribosyltransferases into macrophages and monocytes.
Fahrer J; Kuban J; Heine K; Rupps G; Kaiser E; Felder E; Benz R; Barth H
Cell Microbiol; 2010 Feb; 12(2):233-47. PubMed ID: 19840027
[TBL] [Abstract][Full Text] [Related]
9. Binding of Clostridium botulinum C3 exoenzyme to intact cells.
Rohrbeck A; von Elsner L; Hagemann S; Just I
Naunyn Schmiedebergs Arch Pharmacol; 2014 Jun; 387(6):523-32. PubMed ID: 24584821
[TBL] [Abstract][Full Text] [Related]
10. ADP-ribosylation of Rho proteins inhibits sperm motility.
Hinsch KD; Habermann B; Just I; Hinsch E; Pfisterer S; Schill WB; Aktories K
FEBS Lett; 1993 Nov; 334(1):32-6. PubMed ID: 8224222
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a neutralizing monoclonal antibody against botulinum ADP-ribosyltransferase, C3 exoenzyme.
Kamata Y; Hoshi H; Choki H; Kozaki S
J Vet Med Sci; 2002 Sep; 64(9):767-71. PubMed ID: 12399599
[TBL] [Abstract][Full Text] [Related]
12. ADP-ribosylation of the rhoA gene product by botulinum C3 exoenzyme causes Swiss 3T3 cells to accumulate in the G1 phase of the cell cycle.
Yamamoto M; Marui N; Sakai T; Morii N; Kozaki S; Ikai K; Imamura S; Narumiya S
Oncogene; 1993 Jun; 8(6):1449-55. PubMed ID: 8502473
[TBL] [Abstract][Full Text] [Related]
13. The mammalian G protein rhoC is ADP-ribosylated by Clostridium botulinum exoenzyme C3 and affects actin microfilaments in Vero cells.
Chardin P; Boquet P; Madaule P; Popoff MR; Rubin EJ; Gill DM
EMBO J; 1989 Apr; 8(4):1087-92. PubMed ID: 2501082
[TBL] [Abstract][Full Text] [Related]
14. Purification and activity of the Rho ADP-ribosylating binary C2/C3 toxin.
Haug G; Barth H; Aktories K
Methods Enzymol; 2006; 406():117-27. PubMed ID: 16472654
[TBL] [Abstract][Full Text] [Related]
15. Changes in ADP-ribosylation of rho-related protein by exoenzyme C3 from Clostridium botulinum with maturation in rat testis.
Kurokawa T; Yamashita A; Sato E; Goto M; Ishibashi S
Biochem Int; 1992 Sep; 27(6):1067-71. PubMed ID: 1445375
[TBL] [Abstract][Full Text] [Related]
16. ADP-ribosylation of the rho/rac gene products by botulinum ADP-ribosyltransferase: identity of the enzyme and effects on protein and cell functions.
Narumiya S; Morii N; Sekine A; Kozaki S
J Physiol (Paris); 1990; 84(4):267-72. PubMed ID: 2127805
[TBL] [Abstract][Full Text] [Related]
17. Purification and characterization of an ADP-ribosyltransferase produced by Clostridium limosum.
Just I; Mohr C; Schallehn G; Menard L; Didsbury JR; Vandekerckhove J; van Damme J; Aktories K
J Biol Chem; 1992 May; 267(15):10274-80. PubMed ID: 1587816
[TBL] [Abstract][Full Text] [Related]
18. C3 exoenzyme from Clostridium botulinum: structure of a tetragonal crystal form and a reassessment of NAD-induced flexure.
Evans HR; Holloway DE; Sutton JM; Ayriss J; Shone CC; Acharya KR
Acta Crystallogr D Biol Crystallogr; 2004 Aug; 60(Pt 8):1502-5. PubMed ID: 15272191
[TBL] [Abstract][Full Text] [Related]
19. Entrapment of Rho ADP-ribosylated by Clostridium botulinum C3 exoenzyme in the Rho-guanine nucleotide dissociation inhibitor-1 complex.
Genth H; Gerhard R; Maeda A; Amano M; Kaibuchi K; Aktories K; Just I
J Biol Chem; 2003 Aug; 278(31):28523-7. PubMed ID: 12750364
[TBL] [Abstract][Full Text] [Related]
20. Introduction of C3 exoenzyme into cultured endothelium by lipofectamine.
Borbiev T; Nurmukhambetova S; Liu F; Verin AD; Garcia JG
Anal Biochem; 2000 Oct; 285(2):260-4. PubMed ID: 11017711
[No Abstract] [Full Text] [Related]
[Next] [New Search]
